Concepedia

Estelle Taranchon‐Clermont

ET

Statistics

Publications

6

Citations

165

H-Index

6

Active since

2011

Affiliations

Institut universitaire du cancer de Toulouse Oncopole(Current)

Centre Hospitalier Universitaire de Toulouse

Université Toulouse III - Paul Sabatier

Inserm

Centre National de la Recherche Scientifique

Estelle Taranchon‐Clermont is an author at Institut universitaire du cancer de Toulouse Oncopole specializing in medicine, cancer research, and pathology.

Top concepts

Publications per year

2011–2024

6

Publications

6

Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer

Solène Evrard, Estelle Taranchon‐Clermont, Isabelle Rouquette et al. · Journal of Molecular Diagnostics · 2019 · 48 citations · Full text

Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1

Isabelle Rouquette, Estelle Taranchon‐Clermont, Julia Gilhodes et al. · Biomarker Research · 2019 · 47 citations · Full text

TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression

Charlotte Ruptier, A De Gaspéris, Stéphane Ansieau et al. · Oncogene · 2011 · 28 citations

, , +13

CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies

Jordi Remón, N. Abedallaa, Estelle Taranchon‐Clermont et al. · Lung Cancer · 2017 · 17 citations

, , +6

Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies

Sarah Figarol, Célia Delahaye, Rémi Gence et al. · Nature Communications · 2024 · 14 citations · Full text

1–5 of 6